Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study.

Published in: BMC health services research (2021)

We find that the use of Remdesivir and/or Dexamethasone is effective from an economic standpoint.

Keyphrases